These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22285893)

  • 1. Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer.
    Chan CJ; Andrews DM; Smyth MJ
    Curr Opin Immunol; 2012 Apr; 24(2):246-51. PubMed ID: 22285893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance.
    Fuchs A; Colonna M
    Semin Cancer Biol; 2006 Oct; 16(5):359-66. PubMed ID: 16904340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vγ9Vδ2 T cells.
    Dessarthe B; Thedrez A; Latouche JB; Cabillic F; Drouet A; Daniel P; de La Pintière CT; Catros V; Toutirais O
    J Immunol; 2013 May; 190(9):4868-76. PubMed ID: 23530148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nectins and nectin-like receptors DNAM-1 and CRTAM: new ways for tumor escape].
    Catros V; Dessarthe B; Thedrez A; Toutirais O
    Med Sci (Paris); 2014 May; 30(5):537-43. PubMed ID: 24939541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
    Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V
    Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
    Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A
    Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.
    de Andrade LF; Smyth MJ; Martinet L
    Immunol Cell Biol; 2014 Mar; 92(3):237-44. PubMed ID: 24343663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM.
    Boles KS; Barchet W; Diacovo T; Cella M; Colonna M
    Blood; 2005 Aug; 106(3):779-86. PubMed ID: 15811952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of cell adhesion molecule nectin-2/CD112 and its binding to immune receptor DNAM-1/CD226.
    Liu J; Qian X; Chen Z; Xu X; Gao F; Zhang S; Zhang R; Qi J; Gao GF; Yan J
    J Immunol; 2012 Jun; 188(11):5511-20. PubMed ID: 22547693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy.
    Jin HS; Park Y
    BMB Rep; 2021 Jan; 54(1):2-11. PubMed ID: 33298247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.
    Sanchez-Correa B; Valhondo I; Hassouneh F; Lopez-Sejas N; Pera A; Bergua JM; Arcos MJ; Bañas H; Casas-Avilés I; Durán E; Alonso C; Solana R; Tarazona R
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
    Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
    Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterotypic interaction of CRTAM with Necl2 induces cell adhesion on activated NK cells and CD8+ T cells.
    Arase N; Takeuchi A; Unno M; Hirano S; Yokosuka T; Arase H; Saito T
    Int Immunol; 2005 Sep; 17(9):1227-37. PubMed ID: 16091383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competition of cell adhesion and immune recognition: insights into the interaction between CRTAM and nectin-like 2.
    Zhang S; Lu G; Qi J; Li Y; Zhang Z; Zhang B; Fan Z; Yan J; Gao GF
    Structure; 2013 Aug; 21(8):1430-9. PubMed ID: 23871486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy.
    Wu B; Zhong C; Lang Q; Liang Z; Zhang Y; Zhao X; Yu Y; Zhang H; Xu F; Tian Y
    J Exp Clin Cancer Res; 2021 Aug; 40(1):267. PubMed ID: 34433460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cell receptors as tools in cancer immunotherapy.
    Sentman CL; Barber MA; Barber A; Zhang T
    Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer.
    Wesa AK; Storkus WJ
    Cell Death Differ; 2008 Jan; 15(1):51-7. PubMed ID: 17948028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and structural basis of TIGIT: Nectin-4 interaction, a recently discovered pathway crucial for cancer immunotherapy.
    Ganguli N; Kumari P; Dash S; Samanta D
    Biochem Biophys Res Commun; 2023 Oct; 677():31-37. PubMed ID: 37542773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.